Tvardi Therapeutics, Inc. - ROE
TVRD
Price:
$2.14
Market Cap:
$20.08M
Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting signal transducer and activator of transcription 3 (STAT3) to treat inflammatory and proliferative diseases with significant unmet need in the United States. The company's lead product candidates include TTI-101, which is in Phase 1b/2 clinical development stage for fibrosis-driven diseases with an initial focus on idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC); and TTI-109, an oral, small molecule STAT3 inhibitor which is in Phase-1 clinical trial stage. Tvardi Therapeutics, Inc. was founded in 2017 and is based in ...[Read more]
Industry
Biotechnology
IPO Date
2014-01-31
Stock Exchange
NASDAQ
Ticker
TVRD
PE Ratio
[-0.69]
ROE
[-64.17%]
Current Ratio
[2.25]
Dividend Yield
[0%]
Enterprise Value
[399.08K]
Dividend History
The ROE as of July 2026 (TTM) for Tvardi Therapeutics, Inc. (TVRD) is -64.17%
According to Tvardi Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -64.17%. This represents a change of 188.97% compared to the average of -22.20% of the last 4 quarters.
Tvardi Therapeutics, Inc. (TVRD) Historical ROE (quarterly & annually)
How has TVRD ROE performed in the past?
The mean historical ROE of Tvardi Therapeutics, Inc. over the last ten years is 300.20%. The current -64.17% ROE has changed -121.37% with respect to the historical average. Over the past ten years (40 quarters), TVRD's ROE was at its highest in in the December 2024 quarter at 276.66%. The ROE was at its lowest in in the September 2024 quarter at -779.77%.
Average
300.20%
Median
96.55%
Minimum
-86.96%
Maximum
1.54%
Tvardi Therapeutics, Inc. (TVRD) ROE by Quarter and Year
Discovering the peaks and valleys of Tvardi Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 707.94%
Maximum Annual ROE = 1.54%
Minimum Annual Increase = -1250.89%
Minimum Annual ROE = -86.96%
| Year | ROE | Change |
|---|---|---|
| 2025 | -86.96% | -105.64% |
| 2024 | 1.54% | 707.94% |
| 2023 | 190.97% | 0.66% |
| 2022 | 189.73% | -588.09% |
| 2021 | -38.87% | -1250.89% |
Tvardi Therapeutics, Inc. (TVRD) Average ROE
How has TVRD ROE performed in the past?
The current ROE of Tvardi Therapeutics, Inc. (TVRD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
548.98%
5-year avg
359.56%
10-year avg
300.20%
Tvardi Therapeutics, Inc. (TVRD) ROE vs. Peers
How is TVRD’s ROE compared to its peers?
Tvardi Therapeutics, Inc.’s ROE is less than CalciMedica, Inc. (4.09%), greater than Lantern Pharma Inc. (-198.35%), greater than LAVA Therapeutics N.V. (-99.17%), greater than Actinium Pharmaceuticals, Inc. (-218.67%), greater than Elutia Inc (-560.64%), greater than PDS Biotechnology Corporation (-346.03%), greater than Reviva Pharmaceuticals Holdings, Inc. (-220.39%), greater than Xilio Therapeutics, Inc. (-117.24%), greater than Tempest Therapeutics, Inc. (-729.89%), greater than FibroGen, Inc. (-234.28%),
| Company | ROE | Market cap |
|---|---|---|
| 4.09% | $11.73M | |
| -198.35% | $32.03M | |
| -99.17% | $45.77M | |
| -218.67% | $26.26M | |
| -560.64% | $38.90M | |
| -346.03% | $37.45M | |
| -220.39% | $5.38M | |
| -117.24% | $59.83M | |
| -729.89% | $3.96M | |
| -234.28% | $36.69M |
Build a custom stock screener for Tvardi Therapeutics, Inc. (TVRD) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tvardi Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Tvardi Therapeutics, Inc. (TVRD) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Tvardi Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Tvardi Therapeutics, Inc.'s ROE?
How is the ROE calculated for Tvardi Therapeutics, Inc. (TVRD)?
What is the highest ROE for Tvardi Therapeutics, Inc. (TVRD)?
What is the 3-year average ROE for Tvardi Therapeutics, Inc. (TVRD)?
What is the 5-year average ROE for Tvardi Therapeutics, Inc. (TVRD)?
How does the current ROE for Tvardi Therapeutics, Inc. (TVRD) compare to its historical average?